Not applicableStudy completedNCT00937066What this trial is testingCost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)Who this might be right forAsthma AstraZeneca 1,000
Testing effectiveness (Phase 2)Study completedNCT01479595What this trial is testingEstablish the Efficacy of QBX258 in Patients With Moderate to Severe AsthmaWho this might be right forAsthma Novartis Pharmaceuticals 65
Not applicableWithdrawnNCT00853411What this trial is testingAsthma Exacerbation StudyWho this might be right forAsthma University of Pittsburgh
Early research (Phase 1)Study completedNCT05006521What this trial is testingSingle and Multiple Ascending Dose Study of KN-002Who this might be right forAsthma COPD Kinaset Therapeutics Inc 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT06376045What this trial is testingA Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaWho this might be right forAsthma Amgen 317
Large-scale testing (Phase 3)Study completedNCT00314574What this trial is testingOmalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)Who this might be right forAsthma Genentech, Inc. 850
Post-approval studies (Phase 4)Study completedNCT01476059What this trial is testingPediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECTWho this might be right forAsthma GlaxoSmithKline 472
Large-scale testing (Phase 3)Study completedNCT00563056What this trial is testingAn Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaWho this might be right forAsthma Bronchiale Mundipharma Research Limited 227
Testing effectiveness (Phase 2)Study completedNCT04570657What this trial is testingStudy to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe AsthmaWho this might be right forAsthma AstraZeneca 250
Post-approval studies (Phase 4)Study completedNCT01304901What this trial is testingEffect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.Who this might be right forAsthmaAcute Asthma Kecioren Education and Training Hospital 80
Post-approval studies (Phase 4)Looking for participantsNCT07241117What this trial is testingCHEST: A Collaboration With Community HEalth Centers to Implement SmarT for AsthmaWho this might be right forModerate to Severe Asthma Washington University School of Medicine 2,000
Testing effectiveness (Phase 2)Study completedNCT05186909What this trial is testingCM310 in Subjects With Moderate to Severe AsthmaWho this might be right forAsthma Keymed Biosciences Co.Ltd 52
Large-scale testing (Phase 3)Study completedNCT00476268What this trial is testingEfficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent AsthmaWho this might be right forAsthma Chiesi Farmaceutici S.p.A. 824
Large-scale testing (Phase 3)Study completedNCT00642122What this trial is testingAdults With Moderate to Severe AsthmaWho this might be right forAsthma AstraZeneca 900
Large-scale testing (Phase 3)Study completedNCT00476073What this trial is testingEfficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible AsthmaWho this might be right forAsthma Bronchiale Mundipharma Research Limited 228
Post-approval studies (Phase 4)Study completedNCT00670930What this trial is testingEfficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonistsWho this might be right forAllergic Asthma Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)UnknownNCT06642961What this trial is testingA Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe AsthmaWho this might be right forAsthma Genrix (Shanghai) Biopharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT01340209What this trial is testingEvaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent AsthmaWho this might be right forAsthma Boehringer Ingelheim 285
Not applicableActive Not RecruitingNCT06771934What this trial is testingCombination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe AsthmaWho this might be right forAllergic Asthma Qianfoshan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00411567What this trial is testingAssess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial AsthmaWho this might be right forBronchial Asthma Novartis 26